WuXi Biologics (Cayman) Inc. (2269.HK) News
Follow WuXi Biologics (Cayman) Inc. (2269.HK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
WuXi Biologics remains in Hang Seng ESG 50 Index
WuXi Biologics retained inclusion in the Hang Seng ESG 50 Index, extending capital-market recognition of its ESG performance. Also remained in the Hang Seng Corporate Sustainability Benchmark Index, reinforcing its susta
NEWS | Oct 14, 2026, 11:40 AM UTC
L
WuXi Biologics remains in Hang Seng ESG 50 Index after latest sustainability review
WuXi Biologics will remain in the Hang Seng ESG 50 Index. * It will also stay in the Hang Seng Corporate Sustainability Benchmark Index. The inclusions follow an A+ rating in the Hong Kong Quality Assurance Agency’s 2026
NEWS | Oct 14, 2026, 11:40 AM UTC